Meiji Seika Pharma Files Japan Lawsuit Over Kostaive Misinformation

Mysterious Twist In Vaccine Saga

The Japanese pharma firm has sued a politician claiming defamatory actions on social media around its novel COVID-19 vaccine.

Meiji Seika Pharma filed a defamation lawsuit on Kostaive, revealing a strange finding about a mysterious bestseller. (Shutterstock)

A misinformation dispute in Japan over Arcturus Therapeutics' COVID-19 vaccine Kostaive (ARCT-154) saw an unprecedented twist in December, when local distributor Meiji Seika Pharma decided to pursue a lawsuit and internal investigation over an Amazon bestseller book.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Japan

More from Therapy Areas